300
Participants
Start Date
December 19, 2023
Primary Completion Date
December 31, 2025
Study Completion Date
December 31, 2026
Dexmedetomidine
Intranasal dexmedetomidine 3 mcg/kg \[100 mcg/mL (max 200 mcg or 2 mL)
Midazolam Nasal Spray
Intranasal midazolam 0.4 mg/kg \[5 mg/mL (max 10 mg or 2 mL)
Nitrous oxide
50% nitrous oxide in 50% oxygen by face mask
RECRUITING
London Health Sciences Centre, London
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
OTHER